✨ Lidocaine Hydrochloride (CAS 73-78-9) | Pharmaceutical-Grade Local Anesthetic & Antiarrhythmic Agent ✨
🧪 Product Overview
Lidocaine Hydrochloride (CAS 73-78-9) is a widely used amide-class local anesthetic and antiarrhythmic drug with the molecular formula C₁₄H₂₂N₂O·HCl and a molecular weight of 270.80. This white crystalline powder (purity ≥99%) is essential for pain management in clinical settings and serves as a critical intermediate in pharmaceutical manufacturing. It provides rapid, reversible nerve blockade and stabilizes cardiac membranes in arrhythmia treatment.
Key Functions:
Induces local anesthesia for surgical and diagnostic procedures.
Reduces ventricular arrhythmias in emergency care.
Acts as a reference standard in drug quality control.
Target Industries: Pharmaceuticals, hospitals, and research laboratories.
⭐ Key Advantages
| 🔹 High Purity | 🔹 Flexible Packaging | 🔹 Stability |
|---|
| ≥99% HPLC-certified | 10mg to 25kg bulk options | Stable at 2–8°C |
| Batch-specific COA | Tamper-evident seals | Long-term storage |
🏭 Applications
- Local Anesthesia
: Topical creams, sprays, and injectables for minor surgeries.
- Cardiac Care
: Intravenous administration for arrhythmia control.
- Pharmaceutical R&D
: Impurity profiling and API synthesis.
📊 Quality Assurance
- Testing Standards
: Complies with
USP/EP pharmacopeial requirements.
- Analytical Methods
: HPLC, NMR, and mass spectrometry validation.
- Certifications
: ISO 9001 and GMP compliance for pharmaceutical use.
📈 Market Insights
The global local anesthetics market is projected to grow at 6.1% CAGR (2025–2030), driven by rising surgical volumes and demand for minimally invasive therapies. Lidocaine remains a cornerstone in emergency medicine, with Asia-Pacific emerging as a key growth region due to expanding healthcare access.
China
